Seeking to Play Intellia’s Ground-Breaking Gene Therapy?
July 06, 2021 at 15:00 PM EDT
Intellia Therapeutics CEO John Leonard believes that gene-editing therapy could come to market “very, very soon,” according to an interview on CNBC’s Closing Bell , after news broke that CRISPR-based medicine was recently applied in a systemic delivery to a human in a breakthrough trial.